BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Ligusticum Chuanxiong

200+ PubMed studies analyzed · Evidence Score: 31.5

Research Domains

Ligusticum Chuanxiong has been studied across 22 research domains including 🔬 Inflammation, 🔬 Oncology, ❤️ Cardiovascular, 🫁 Liver & Detox, 🧠 Neuroprotection. The primary research focus is 🔬 Inflammation with 14% of studies addressing this area.

Traditional Use (Ayurveda)

Known as chuanxiong / 芎藭 in Ayurveda. Virya (potency): Liver. Karma (actions): Dispels Wind and enters the brain, Warms the interior, Dries dampness, Stops dysentery and diarrhea, Moves Qi and opens constraint, Tonifies the five labors, Strengthens sinews and bones, Regulates the vessels, Breaks concretions and old Blood stagnation, Nourishes new Blood, Disperses static Blood, Searches Liver Qi, Tonifies Liver Blood, Moistens Liver dryness, Tonifies Wind deficiency, Promotes expulsion of the placenta, Generates flesh and expels pus.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ligusticum Chuanxiong, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rehmannia
5581 shared targets
verbena
5396 shared targets
Nelumbo
5961 shared targets
citrus
6110 shared targets
paeonia
5063 shared targets
bupleurum
5746 shared targets
Panax
6305 shared targets
scutellaria
5732 shared targets
Syzygium
5550 shared targets
mentha
5193 shared targets
Loading evidence profile...

This evidence profile for Ligusticum Chuanxiong is generated deterministically from 200 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.